Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma

被引:49
作者
vandenBrekel, MWM
Hekkenberg, RJ
Asa, SL
Tomlinson, G
Rosen, IB
Freeman, JL
机构
[1] UNIV TORONTO,MT SINAI HOSP,DEPT OTORHINOLARYNGOL,TORONTO,ON M5G 1X5,CANADA
[2] UNIV TORONTO,MT SINAI HOSP,DEPT PATHOL,TORONTO,ON M5G 1X5,CANADA
[3] UNIV TORONTO,MT SINAI HOSP,DEPT BIOSTAT,TORONTO,ON M5G 1X5,CANADA
[4] UNIV TORONTO,MT SINAI HOSP,DEPT SURG,TORONTO,ON M5G 1X5,CANADA
关键词
thyroid carcinoma; histopathology; tall cell papillary carcinoma; insular cell carcinoma; anaplastic carcinoma; prognosis;
D O I
10.1097/00005537-199702000-00020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tall cell papillary carcinoma (TCPC) and insular carcinoma (IC) are variants of thyroid carcinoma that are considered to be more aggressive than well differentiated papillary or follicular carcinoma. To determine the clinical significance of these diagnoses, we evaluated 65 patients with these tumors. There were 30 TCPCs, 27 ICs, and 8 ICs or TCPCs with focal anaplastic carcinoma (FAG). Forty-two patients (27 TCPCs, 14 ICs, and I FAG) are alive and free of disease. Nine patients with IC are alive with distant metastases. Ten patients (2 TCPCs, 2 ICs, and 7 FACs) died of disease. Univariate analysis of disease-free interval determined that, as for all thyroid carcinomas, patient age, tumor size, extrathyroidal extension, and lymph node metastases were significant for prognosis. ICs did significantly worse than TCPCs. Focal anaplastic dedifferentiation predicted a worse prognosis. Multivariate analysis for disease-free interval showed age, number of lymph node metastases, and tumor type to be significant, Analysis of the same factors for prediction of mortality showed that TCPC and IC mere not significantly different. These data suggest that TCPC is less aggressive than IC, which often results in disseminated disease. Focal AC predicts poor survival.
引用
收藏
页码:254 / 259
页数:6
相关论文
共 26 条
[1]   THYROID-CARCINOMA WITH MIXED TALL-CELL AND COLUMNAR-CELL FEATURES [J].
AKSLEN, LA ;
VARHAUG, JE .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (04) :442-445
[2]  
ASHFAQ R, 1994, CANCER, V73, P416, DOI 10.1002/1097-0142(19940115)73:2<416::AID-CNCR2820730229>3.0.CO
[3]  
2-O
[4]  
BRONNER MP, 1991, MODERN PATHOL, V4, P637
[5]   POORLY DIFFERENTIATED (INSULAR) THYROID-CARCINOMA - A REINTERPRETATION OF LANGHANS WUCHERNDE STRUMA [J].
CARCANGIU, ML ;
ZAMPI, G ;
ROSAI, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1984, 8 (09) :655-668
[6]   PROGNOSTIC FACTORS AND MANAGEMENT CONSIDERATIONS IN PATIENTS WITH CERVICAL METASTASES OF THYROID-CANCER [J].
COBURN, MC ;
WANEBO, HJ .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (06) :671-676
[7]   STEPWISE PARTICIPATION OF P53 GENE MUTATION DURING DEDIFFERENTIATION OF HUMAN THYROID CARCINOMAS [J].
DOBASHI, Y ;
SUGIMURA, H ;
SAKAMOTO, A ;
MERNYEI, M ;
MORI, M ;
OYAMA, T ;
MACHINAMI, R .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1994, 3 (01) :9-14
[9]  
FLYNN SD, 1988, SURGERY, V104, P963
[10]   MANY APPEARANCES OF PAPILLARY CARCINOMA OF THYROID [J].
HAWK, WA ;
HAZARD, JB .
CLEVELAND CLINIC QUARTERLY, 1976, 43 (04) :207-216